In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...
Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...
In this video, Girish N Nadkarni, MD, a professor of medicine at the Icahn School of Medicine at Mount Sinai, discusses recent advancements in chronic kidney disease care.
The US Food and Drug Administration (FDA) has broadened the approval of Furoscix (furosemide injection) to treat edema in ...
Medical Xpress on MSN12d
FDA-approved dialysis drug may help fight against antimicrobial resistanceIncreased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...
3d
March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...
Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...
Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.
The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the ...
A drug already used to treat people who have diabetes and/or chronic kidney disease could have added heart disease benefits, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback